Spinal extranodal Rosai-Dorfman disease: A case report and literature review

Mahzoni, 2012, Intracranial ROSAI-DORFMAN disease, J. Res. Med. Sci., 17, 304 K. Z, B. O, S. A, D. C, M. MC, Rosai-Dorfman disease: a case report with nodal and cutaneous involvement and review of the literature, Am. J. Dermatopathol. 36 (2014) 353–357. doi:10.1097/DAD.0B013E31829E5564. Rosai, 1969, Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity, Arch. Pathol., 87, 63 Foucar, 1990, Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity, Semin. Diagn. Pathol., 7, 19 Th, 2016, Cutaneous Rosai-Dorfman disease of the face: a comprehensive literature review and case report, J. Oral Maxillofac. Surg., 74, 528, 10.1016/j.joms.2015.09.017 Abla, 2018, Consensus recommendations for the diagnosis and clinical management of rosai-dorfman-destombes disease, Blood, 131, 2877, 10.1182/blood-2018-03-839753 G. G, Y. JR, K. MJ, T. WO, V. R, R. JH, D.-P. CJ, H. MD, R. A, SV JC, B. NN, S. MV, R. KL, G. RS, The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease, Mayo Clin. Proc. 94 (2019) 2054–2071. doi:10.1016/J.MAYOCP.2019.02.023. Agha, 2020, The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines, Int. J. Surg., 84, 226, 10.1016/j.ijsu.2020.10.034 E. JF, A. O, F. S, H. A, H. J, D. J, R.-C. L, J. MB, A.-W. O, A. CE, C. F, D. EL, E. RM, F. A, H. JG, H. JI, J. F, M. M, P. J, R.-G. C, R. BJ, T. A, V. R, W. LM, Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages, Blood. 127 (2016) 2672–2681. doi:10.1182/BLOOD-2016-01-690636. B. SS, M. H, M. Y, B. M, A. J, Long-term outcome of spinal extranodalRosai-Dorfman disease: a report of two cases and systematic review, World Neurosurg. 144 (2020) 1–14. doi:10.1016/J.WNEU.2020.08.097. Luppi, 1998, Expression of human Herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases, Am. J. Pathol., 153, 815, 10.1016/S0002-9440(10)65623-4 Mehraein, 2006, Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations, J. Clin. Pathol., 59, 1320, 10.1136/jcp.2005.029850 Hu, 2021, Diagnosis and treatment of Rosai-Dorfman disease of the spine: a systematic literature review, Syst. Rev., 10, 1, 10.1186/s13643-021-01581-0 R. V, D. M, HR PV, V. P, Rosai-Dorfman disease: report of a 3-year-old girl with critical review of treatment options, Eur. J. Pediatr. Surg. 13 (2003) 350–354. doi:10.1055/S-2003-43578. U. J, U. S, K. H, E. P, R. A, H. A, N. T, H. R, H. U, G. S, S. D, Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses, Arch. Dermatol. 143 (2007) 736–740. doi:10.1001/ARCHDERM.143.6.736.